The human MHC class Ib antigen HLA-G is thought to regulate maternal immune
responses during pregnancy. Here we show that expression of HLA-G in trans
genic mice diminished cellular immunity by inhibiting maturation of myelomo
nocytic cells into functional antigen-presenting cells (APC), Skin allograf
ts applied to HLA-G transgenic mice survived longer and resultant T cell re
sponses were less potent compared to control mice, T cells from HLA-G mice
responded normally to allogeneic APC and immunohistological analyses of spl
een revealed no marked abnormalities. However, spontaneous outgrowths of my
eloid cells were observed when bone marrow or splenocytes from HLA-G mice w
ere cultured in vitro, but functionally competent APC did not develop spont
aneously in bone marrow cultures supplemented with granulocyte macrophage c
olony stimulating factor (GM-CSF). Addition of lipopolysaccharide (LPS) to
GM-CSF-derived bone marrow cultures rescued APC maturation. Studies using H
LA-G tetrameric reagents revealed that HLA-G-specific binding activity was
associated with CD11c(+) myelomonocytic cells, while binding to lymphoid an
d NK cell subsets was undetectable, These data show that spontaneous matura
tion of functionally competent dendritic cells IDC) is compromised in HLA-G
mice. We hypothesize that HLA-G inhibits maturation of DC via receptor-med
iated interactions with myelomonocytic precursors, which render immature DC
precursors unable to receive signals from activated T cells.